What are the main evidence limits for PT-141 / Bremelanotide?
An approval for Vyleesi does not validate every product sold as PT-141 or use in populations outside the label.
DIRECT ANSWER
PT-141 / Bremelanotide evidence limits.
An approval for Vyleesi does not validate every product sold as PT-141 or use in populations outside the label.
Reviewed August 8, 2026. Each statement links to its evidence record, followed by the primary and official sources used for this answer.
An approval for Vyleesi does not validate every product sold as PT-141 or use in populations outside the label.
Open evidence recordTwo randomized phase 3 trials support branded bremelanotide for acquired, generalized HSDD in premenopausal women.
Open evidence recordEvidence-depth scores do not establish effectiveness, safety, product quality, or personal suitability.
Open evidence recordPRIMARY & OFFICIAL SOURCES
Sources for this answer.
3 source records, with duplicates removed.